Mitochondrial Dysfunction May Explain Prostate Cancer Disparity
Mechanism may explain prostate cancer treatment resistance among African-American men
Additional Treatments Offer Little Benefit for Pancreatic Cancer
Neither extra chemotherapy drug nor add-on radiation aided longevity in French trial
Radon in the Home Linked to Hematologic Malignancies
Association seen in women, but no connection found in men
Physician Leadership Training May Help Counteract Burnout
Leadership ratings strongly linked to employee burnout and satisfaction
All-Cause, CVD, DM Mortality Down From 2000 to 2011
Decreases seen in type 1 and 2 diabetes; no change in age-standardized cancer-specific mortality
Report: Why Health Care Costs Are Lower in Europe Than U.S.
Main reason for price difference is national system that negotiates with medical providers
Well Water a Suspected Cause of Bladder Cancer in New England
Researchers believe arsenic exposure might contribute to higher-than-normal rates
Adding Antiviral to Sorafenib Is Cost-Effective in HCC
More cost-effective than sorafenib monotherapy for HBV-related cancer
April 2016 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for April 2016. This roundup includes...
2017 May Offer Fewer Choices for Affordable Care Act Enrollees
UnitedHealth's exit from most marketplaces highlights health exchanges' growing pains
